These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2973852)

  • 21. [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
    Dubenko OE; Ermakovich II
    Vrach Delo; 1988 Mar; (3):39-42. PubMed ID: 3394295
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes induced by D-thyroxine treatment in blood lipid indices in arteriosclerotic subjects].
    Notarbartolo A; Di Fede G; Cupidi G; Rini GB
    Boll Soc Ital Biol Sper; 1974 Aug; 50(13):979-83. PubMed ID: 4463989
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparative study of the fibrinolytic activity of dimethylbiguanide in prevention of thromboembolism in patients with angiocardiopathy].
    Molino N; Belluardo C
    Rass Int Clin Ter; 1968 Jun; 48(11):687-700. PubMed ID: 5738544
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of atherosclerosis with cobalt-containing preparations].
    Khodzhaev AKh; Ashirmatov AE; Mirochnik LM
    Klin Med (Mosk); 1972 Jan; 50(1):77-82. PubMed ID: 5020034
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experience with polysponin therapy of atherosclerosis].
    Milimovka ME; Konovalov MN; Rybnikov NI; Dimant MI
    Vrach Delo; 1971 Jan; (1):63-5. PubMed ID: 5576585
    [No Abstract]   [Full Text] [Related]  

  • 26. [Thiadenol in the short-term treatment of patients with blood lipid disorders].
    Di Stefano F; Patane S; Gatto A
    Minerva Med; 1980 Mar; 71(8):567-74. PubMed ID: 7360386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined intenkordin and corhormone treatment of ischemic heart disease].
    Glukhen'kiĭ TT; Kuz'ko NV
    Vrach Delo; 1974 May; 5(0):55-7. PubMed ID: 4407764
    [No Abstract]   [Full Text] [Related]  

  • 28. [Antithrombogenic action of a new extract: 3GS].
    Rusconi C; Orlando G
    Minerva Cardioangiol; 1975 Sep; 23(9):565-70. PubMed ID: 125860
    [No Abstract]   [Full Text] [Related]  

  • 29. [Indications for surgical treatment and medical treatment of atherosclerosis].
    Paredero Del Bosque Martin V
    Minerva Med; 1980 Oct; 71(40):2963-7. PubMed ID: 7454082
    [No Abstract]   [Full Text] [Related]  

  • 30. Sulodexide: a renewed interest in this glycosaminoglycan.
    Lauver DA; Lucchesi BR
    Cardiovasc Drug Rev; 2006; 24(3-4):214-26. PubMed ID: 17214598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 32. [Behavior of the thromboelastogram (TEG) in arteriosclerotic subjects treated with natural mucopolysaccharide substances].
    Garbagnati N; Iaschi P; Ciavarelli F; Carignola W
    Clin Ter; 1969 Jul; 50(2):125-31. PubMed ID: 4243098
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effectiveness and tolerability of heparan sulfate in the treatment of superficial thrombophlebitis. Controlled clinical study vs sulodexide].
    Messa G; La Placa G; Puccetti L; Di Perri T
    Minerva Cardioangiol; 1997 Apr; 45(4):147-53. PubMed ID: 9213829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regression of arteriosclerosis. Results of animal experiments and human medical studies, results of drug therapy].
    Kaffarnik H; Zehner J
    Fortschr Med; 1985 May; 103(20):531-4. PubMed ID: 4007752
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thallium-201 myocardial perfusion imaging after aortocoronary bypass in patients treated with sulodexide or ASA-dipyridamole].
    Astorri E; Saccani S; Beghi C; Raise G
    Minerva Cardioangiol; 1993 Oct; 41(10):425-31. PubMed ID: 8302438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of a sulfomucopolysaccharide (3GS) in the treatment of hyperlipoproteinemias].
    Palmieri G; Perego M; Nazzari M; Casalini F
    Clin Ter; 1982 Jun; 101(6):603-14. PubMed ID: 7128029
    [No Abstract]   [Full Text] [Related]  

  • 37. [The effects of oral administration of a sulfo-polysaccharide of low molecular weight in a group of sedentary workers with ateriosclerotic cardiovascular disease].
    Alessandri M; Fiorentini P; Garagnani C
    G Clin Med; 1967 Sep; 48(9):935-47. PubMed ID: 4180085
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapeutic trial with plasmaclar in arteriosclerotic patients and modification of their cholesterol rates].
    Casado Salvador F
    Folia Clin Int (Barc); 1976 Sep; 26(9):415-9. PubMed ID: 793885
    [No Abstract]   [Full Text] [Related]  

  • 39. [Non-invasive diagnosis and medical therapy of cerebral and/or peripheral atherosclerotic vasculopathies].
    Rezzo R; Stabilini L; Bertoglio C; Ruben G; De Gregori M; Fontana G; Gori A; Petrilli GL
    Clin Ter; 1984 Dec; 111(6):495-511. PubMed ID: 6396028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Use of grandaxin in the complex treatment of patients with initial atherosclerotic encephalopathy].
    Mints AIa; Garmash IuIu; Boĭko NR
    Vrach Delo; 1985 May; (5):96-9. PubMed ID: 4013237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.